Moxifloxacin Hydrochloride Tablet, Film Coated
Product Images NDC 57237-156

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Moxifloxacin Hydrochloride (NDC 57237-156). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Moxifloxacin Fig1)

A line graph depicting plasma concentration (mcg/mL) over time (hours) for oral and intravenous doses of a drug. The graph shows plasma concentration peaking shortly after administration with a decline over 24 hours, comparing oral dose (circles) and intravenous dose (squares).*

FDA Label Image

Package Label-principal Display Panel (400 mg (30 Tablets Bottle))

Label for Moxifloxacin Hydrochloride 400 mg film-coated tablets by Rising Pharma Holdings, Inc. The label shows it contains 30 tablets. It includes storage information, distributor details (Rising Health, LLC, Saddle Brook, NJ), a barcode, and notes on packaging zones. Made in India is also stated.*

FDA Label Image

Structure (Moxifloxacin Str)

Chemical structure of Moxifloxacin Hydrochloride, showing its detailed molecular components including rings and functional groups such as fluorine, hydroxyl, and hydrochloride elements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.